Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP) - Fensterer, Heiko; Märten, Angela; Ebert, Matthias; Hofheinz, Ralf-Dieter (Annals of oncology, 2013)
Gesehen am: 07.08.2014